Which gene fragments does erlotinib hydrochloride act on?

Erlotinib hydrochloride, as an anti-cancer drug, mainly acts on specific gene fragments to exert its therapeutic effect. The following is a detailed analysis of the gene fragments acted upon by erlotinib hydrochloride:

1. Main gene fragment:EGFRgene

EGFR (Epidermal Growth Factor Receptor) gene is the main target of erlotinib hydrochloride. Specifically, erlotinib is a tyrosine kinase inhibitor of EGFR/human epidermal growth factor receptorI (also known as HER1). It interferes with cell signaling pathways by inhibiting the intracellular EGFR phosphorylation process, thereby triggering cell growth arrest and cell death.

In non-clinical trial models, inhibition of EGFR phosphorylation has been observed to result in cell growth arrest and / or cell death. EGFR mutations can activate anti-apoptosis and proliferation signaling pathways, and erlotinib can effectively block these signaling pathways mediated by EGFR mutations.

Erlotinib tightly binds to the ATP binding site in the EGFR mutant kinase domain, causing the downstream signaling pathways to be blocked, cell proliferation to be inhibited, and cell death to be induced through the intrinsic apoptotic pathway.

2. The influence of other related gene fragments

In addition to directly acting on the EGFR gene, erlotinib hydrochloride may also indirectly affect other gene segments related to tumor growth and metastasis. For example, erlotinib can downregulate the expression of vascular endothelial growth factor (VEGF), reduce the proliferation of endothelial cells and the formation of new blood vessels, thereby limiting the blood supply to tumor tissues.

In addition, erlotinib may also promote apoptosis in cancer cells by upregulating the expression of pro-apoptotic genes (such asBax) and downregulating the expression of anti-apoptotic genes (such asBcl-2). At the same time, it can also reduce the expression level of matrix metalloproteinases (such asMMP-9) and hinder the ability of tumor cells to spread from the original site to surrounding tissues.